See Credit Details Below
Overview
Why You Should Attend:
This Studio Briefing addresses practical legal considerations following the Department of Justice notice of proposed rulemaking to reschedule marijuana from Schedule I to Schedule III, under the Controlled Substances Act. Our faculty address some of the immediate and longer-term implications of the proposal, relevant federal agency coordination and how counsel can prepare for certain developments that may impact manufacturers, companies, consumers, patients and other related parties.
What You Will Learn:
After completing this program, participants will be able to:
- Review the role of federal agencies: DOJ-DEA, HHS-FDA
- Understand related statutes and regulations/rulemaking
- Explain schedule 1 and schedule 3 under the Controlled Substances Act
- Assess considerations and practical implications for manufacturers-companies, individuals-consumers, patients, etc.
Who Should Attend:
Lawyers counseling on matters implicating the Controlled Substances Act and relevant state and local laws should find this program to be helpful.
PLI’s Studio Briefings are on-demand video CLE programs that feature an intimate and engaging round table discussion format with legal and industry experts addressing a range of topics. Visit our landing page for our library of PLI Studio Briefings.